Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Pupillo

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 25, 2017
Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortiumElisabetta Pupillo, Marco Poloni, Elisa Bianchi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 1, 2022
Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: A pragmatic multicentre, prospective, randomized, controlled studyEdoardo Ferlazzo, Giorgia Giussani, Sara Gasparini, et al.
Journal of Neurology|September 8, 2023
Correction to: Retrospective observational study on the use of acetyl-L-carnitine in ALSSerena Sassi, Elisa Bianchi, Luca Diamanti, et al.
Journal of Neurology|June 28, 2023
Retrospective observational study on the use of acetyl-L-carnitine in ALSSerena Sassi, Elisa Bianchi, Luca Diamanti, et al.
Scientific Reports|February 5, 2025
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX)Elisabetta Pupillo, Elisa Bianchi, Ettore Beghi, et al.
European Journal of Neurology|September 23, 2022
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trialEttore Beghi, Elisabetta Pupillo, Elisa Bianchi, et al.
JAMA Neurology|November 2, 2020
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study, Valery L Feigin, Theo Vos, et al.
Nature Genetics|July 26, 2016
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosisWouter van Rheenen, Aleksey Shatunov, Annelot M Dekker, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics|February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 25, 2017
Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortiumElisabetta Pupillo, Marco Poloni, Elisa Bianchi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 1, 2022
Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: A pragmatic multicentre, prospective, randomized, controlled studyEdoardo Ferlazzo, Giorgia Giussani, Sara Gasparini, et al.
Journal of Neurology|September 8, 2023
Correction to: Retrospective observational study on the use of acetyl-L-carnitine in ALSSerena Sassi, Elisa Bianchi, Luca Diamanti, et al.
Journal of Neurology|June 28, 2023
Retrospective observational study on the use of acetyl-L-carnitine in ALSSerena Sassi, Elisa Bianchi, Luca Diamanti, et al.
Scientific Reports|February 5, 2025
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX)Elisabetta Pupillo, Elisa Bianchi, Ettore Beghi, et al.
European Journal of Neurology|September 23, 2022
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trialEttore Beghi, Elisabetta Pupillo, Elisa Bianchi, et al.
JAMA Neurology|November 2, 2020
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study, Valery L Feigin, Theo Vos, et al.
Nature Genetics|July 26, 2016
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosisWouter van Rheenen, Aleksey Shatunov, Annelot M Dekker, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics|February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 6